Both in Pharmaceuticals
Dare Bioscience vs Bolt Biotherapeutics
Over the past year DARE returned −69.4% and BOLT returned +4.5%; their daily moves had a correlation of 0.07.
DARE −69.4% BOLT +4.5%Growth of $1, one year, split-adjusted
| Metric | DARE | BOLT |
|---|---|---|
| Price | $0.6459 | $6.27 |
| Market cap | $12.7M | $12.1M |
| Today | −0.89% | +49.64% |
| 1 month | −12.8% | +74.7% |
| 6 months | −69.4% | +29.8% |
| Year to date | −66.5% | +14.7% |
| 1 year | −68.8% | +11.8% |
| Revenue growth (YoY) | — | −99.7% |
| Gross margin | −70.6% | 100.0% |
| Net margin | −1590.4% | −154400.0% |
| P/E (TTM) | — | — |
| Price / sales | 9.3× | 2.6× |
| Net cash | $12.5M | $17.6M |
| Dividend yield | — | — |
| Volatility (60d) | 100.3% | 110.6% |
| Short % of float | 5.0% | 1.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).